Open access
Open access
Powered by Google Translator Translator

Archives

Just the Facts: What Drugs are Safe and Effective for COVID-19?

27 May, 2020 | 02:31h | UTC

Just the Facts: What drugs are safe and effective for COVID-19? – Canadian Journal of Emergency Medicine

Related Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

“Apart from supportive care, there are no current effective therapeutics for COVID-19”

 


A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2

27 May, 2020 | 02:22h | UTC

A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal

 


Reasons to Worry Less About the Explosion of Preprints

27 May, 2020 | 02:24h | UTC

Reasons to Worry Less About the Explosion of Preprints – Absolutely Maybe Blog

 


Preprinting a Pandemic: The Role of Preprints in the COVID-19 Pandemic

27 May, 2020 | 02:25h | UTC

Preprinting a pandemic: the role of preprints in the COVID-19 pandemic – bioRxiv

 


Duration of Prone Position Sessions: A Prospective Cohort Study

27 May, 2020 | 02:20h | UTC

Duration of prone position sessions: a prospective cohort study – Annals of Intensive Care

 


Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19

27 May, 2020 | 02:21h | UTC

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis – Canadian Medical Association Journal

 


Lyme Borreliosis: Diagnosis and Management

27 May, 2020 | 02:19h | UTC

Lyme borreliosis: diagnosis and management – The BMJ (free for a limited period)

 


Short Review: Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020

27 May, 2020 | 02:18h | UTC

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020 – JAMA (free for a limited period)

 


Randomized Trial: Antihypertensive Medication Reduction vs. Usual Care Among Older Adults Taking Multiple Antihypertensive Medications

27 May, 2020 | 02:16h | UTC

Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial – JAMA

Editorial: Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?

Commentary: Less is more? Deprescribing blood pressure lowering medications is safe in the short-term in older people with frailty and multiple long-term conditions – University of Oxford

 

Related Commentary on Twitter

 


Meta-Analysis: Vasopressin or Its Analogs are Not Associated with Reduced Mortality Compared to Catecholamines Alone in Patients with Septic Shock

27 May, 2020 | 02:13h | UTC

Clinical Efficiency of Vasopressin or Its Analogs in Comparison with Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis – Frontiers in Pharmacology

Related Review: Vasopressin and its analogues in shock states: a review – Annals of Intensive Care (free)

 


The Challenge of Implementing “Less is More” Medicine: A European Perspective

27 May, 2020 | 02:14h | UTC

The challenge of implementing Less is More medicine: A European perspective – European Journal of Internal Medicine

 


[Abstract Only] Study: Estimating the Lifetime Benefits of a Multi-drug Regimen for Heart Failure

27 May, 2020 | 02:41h | UTC

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials – The Lancet (link to abstract – $ for full-text)

Commentary: Multi-drug regimen for heart failure could meaningfully extend patients’ lives – Brigham and Women’s Hospital

 

Related Commentary on Twitter

 


Wed May 27 – 10 Stories of The Day!

27 May, 2020 | 02:50h | UTC

 

1 – Revealing the toll of COVID-19: A technical package for rapid mortality surveillance and epidemic response – World Health Organization

 

2 – WHO Manifesto for a healthy recovery from COVID-19 – World Health Organization

 

3 – “Is It Safe for Me to Go to Work?” Risk Stratification for Workers during the Covid-19 Pandemic – New England Journal of Medicine

 

4 – When You Can be Around Others After You Had or Likely Had COVID-19 – Centers for Disease Control and Prevention

“I think or know I had COVID-19, and I had symptoms”.

You can be with others after:

  • 3 days with no fever AND
  • Symptoms improved AND
  • 10 days since symptoms first appeared”

 

5 – Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19 – Annals of Internal Medicine

 

6 – Just the Facts: What drugs are safe and effective for COVID-19? – Canadian Journal of Emergency Medicine

Related Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

“Apart from supportive care, there are no current effective therapeutics for COVID-19”

 

7 – The Totality of the Evidence – Boston Review

See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science

“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”

 

8 – Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO—a Living Working Document – Circulation: Heart Failure

 

9 – Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis – Canadian Medical Association Journal

 

10 –COVID-19 Updates / 27 May 2020 Edition

27 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Study Shows Abnormalities in Placentas from COVID-19-positive Pregnant Women

26 May, 2020 | 10:00h | UTC

Placental Pathology in COVID-19 – American Journal of Clinical Pathology

Commentaries: Placentas from COVID-19-positive pregnant women show injury – Northwestern University AND Expert reaction to study looking at placentas from COVID19-positive pregnant women – Science Media Centre AND Covid-19 appears to attack placenta during pregnancy, study says – CNN AND Placenta Injury Observed in Pregnant Women Who Test Positive For Coronavirus – Forbes

 


SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines

26 May, 2020 | 10:02h | UTC

SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines – Journal of Clinical Medicine

Related: COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies

 


Review: COVID-19 and Cardiovascular Disease

26 May, 2020 | 10:05h | UTC

COVID-19 and Cardiovascular Disease – Circulation

Related Guidelines: COVID-19 rapid guideline: acute myocardial injury – National Institute for Health and Care Excellence AND ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic – European Society of Cardiology AND Management of Acute Myocardial Infarction During the COVID-19 Pandemic – Journal of the American Academy of Cardiology

 


Podcast: Evidence-Based Medicine for the Management of COVID-19 ARDS

26 May, 2020 | 09:57h | UTC

Critical Perspective: Evidence-Based Medicine for the Management of COVID-19 ARDS – American Thoracic Society

Related Perspective from the Author: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society

 


Perspective: In Pandemic, Many Seeing Upsides to Telemedicine

26 May, 2020 | 09:52h | UTC

Part I: In pandemic, many seeing upsides to telemedicine – CIDRAP

Part II: COVID-19 reveals telehealth barriers, solutions – CIDRAP

 


Report: Smart Testing for COVID-19 Virus and Antibodies

26 May, 2020 | 09:55h | UTC

Smart testing for COVID-19 virus and antibodies – CIDRAP

News Release: In new report, CIDRAP at the University of Minnesota proposes smart and strategic approach to COVID-19 testing

See also: Reports 1 and 2

 


Study: Six Feet May Not Be Far Enough to Stop Coronavirus Transmission

26 May, 2020 | 09:48h | UTC

On coughing and airborne droplet transmission to humans – Physics of Fluids

Commentaries: Six feet not far enough to stop virus transmission in light winds – American Institute of Physics AND Expert reaction to paper studying mechanisms of coughing and airborne transmission of viruses – Science Media Centre AND Why 6 feet may not be enough social distance to avoid COVID-19 – Science News

 


Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients

26 May, 2020 | 09:43h | UTC

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign” – Journal of the American Academy of Dermatology

 


Perspective: “Here’s What Needs to Happen Before We Can All Get Vaccinated for COVID-19”

26 May, 2020 | 09:45h | UTC

Here’s what needs to happen before we can all get vaccinated for COVID-19 – CBC

 


Detailed Report into a Nosocomial Outbreak of COVID-19 in a South African Hospital

26 May, 2020 | 09:38h | UTC

Study tells ‘remarkable story’ about COVID-19’s deadly rampage through a South African hospital – Science

Original Study: Report into a nosocomial outbreak of coronavirus disease 2019 (COVID-19) at Netcare St. Augustine’s Hospital

 

Related Commentary on Twitter

https://twitter.com/EricTopol/status/1264922133722886144

 


Impact of COVID-19 on Oncology Clinical Trials

26 May, 2020 | 09:40h | UTC

Impact of COVID-19 on oncology clinical trials – Nature Reviews Drug Discovery

Commentary: More Than 200 International Cancer Trials Suspended Due to COVID-19 – Medscape (free registration required)

 


WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial Due to Safety Concerns

26 May, 2020 | 09:35h | UTC

WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug – Health Policy Watch

See also: WHO halts hydroxychloroquine trial for coronavirus amid safety fears – The Guardian AND WHO Halts Hydroxychloroquine Trial Over Safety Concerns – NPR

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.